Investigators reported a small, statistically significant association between bilateral internal carotid artery stenosis/occlusion and restless legs syndrome diagnoses in patients without prior stroke or TIA. The matched cohorts each contained 58,382 patients drawn from the TriNetX Global Health Research Network. RLS was recorded in 1,154 (1.977%) of patients with bilateral CAS/occlusion versus 1,060 (1.816%) in matched atherosclerotic controls, producing an absolute risk difference of 0.161% (95% CI 0.005–0.317%; p=0.0437). The adjusted odds ratio calculated by conditional logistic regression was 1.09 (95% CI 1.002–1.186). The study team characterized this as a modest increase in risk that persisted after accounting for several confounders.
The authors queried TriNetX to identify cases defined by ICD-10-CM I65.23 for bilateral carotid artery stenosis/occlusion. Controls were patients with atherosclerosis but without CAS. The source did not report imaging criteria, degree-of-stenosis thresholds, or procedural history used to define CAS beyond the diagnostic code. Patients with prior stroke or transient ischemic attack, iron deficiency, antipsychotic use, and other recognized secondary causes of RLS were excluded. Cases and controls were matched 1:1 using propensity scores for age, race/ethnicity, chronic kidney disease, peripheral neuropathy, peripheral artery disease, Parkinson’s disease, and SSRI use. The manuscript notes that the study was treated as not human subjects research under the authors’ institutional determination; specific IRB documentation details were not included in the source.
Data indicated RLS prevalence of 1.977% in the CAS group versus 1.816% in controls. That translates to an absolute risk difference of 0.161% with a 95% confidence interval narrowly excluding zero and a p-value of 0.0437, meeting conventional thresholds for statistical significance. Conditional logistic regression yielded an adjusted odds ratio of 1.09 (95% CI 1.002–1.186). The authors interpreted this effect size as modest. The source did not provide subgroup analyses, stratified risk estimates by degree of stenosis, or sensitivity analyses beyond the propensity-matched model.
The study team proposed biological plausibility rooted in subclinical vascular effects. They hypothesized that chronic hypoperfusion of subcortical structures or microembolic phenomena from carotid disease could impair dopaminergic pathways in the basal ganglia and thereby precipitate RLS symptoms even in the absence of clinically evident stroke. The source did not include neuroimaging, perfusion measures, biomarkers, or histopathologic data to test these mechanisms directly. Those mechanistic suggestions are therefore inferential and derived from existing pathophysiologic concepts rather than from data presented in this dataset.
Several limitations were acknowledged by the authors or are evident from the report. The analysis relied on diagnostic coding and the TriNetX dataset; the source did not report imaging-confirmed stenosis severity, laterality beyond the bilateral code, or the timing between CAS diagnosis and RLS onset. Residual confounding remains possible despite propensity matching, and absolute risk increment was small. The dataset excluded patients with known stroke/TIA, but subclinical infarcts detectable only by imaging could not be excluded using administrative codes alone. The manuscript did not present data on whether carotid revascularization or medical management of CAS modifies RLS incidence or symptom severity.
Prospective studies were recommended by the authors to address causality, assess dose-dependency by stenosis severity, and determine whether carotid intervention changes RLS risk. The source did not provide details about planned trials, endpoints, or timelines. Authors declared no competing interests and indicated that TriNetX data used in the analysis are publicly available on request.
Study questions that remain open and would guide next steps include: What is the relationship between quantitative measures of carotid stenosis and RLS risk? Can neuroimaging identify subcortical hypoperfusion or microinfarcts correlating with RLS in this population? Does carotid revascularization reduce incident RLS or improve symptoms? These specific questions were called out by the authors as areas for prospective investigation.